Current Research
The Miller Laboratory is fundamentally interested in understanding viral host-pathogen interactions. In particular, the laboratory is focused on characterizing immunological determinants of broad protection against viral pathogens, and the development of broadly protective countermeasures for pandemic prevention and response.
​
The laboratory is particularly interested in mucosal immunity and the development of mucosal vaccines and therapeutics to protect against respiratory viruses, including influenza virus and SARS-CoV-2. The laboratory is also interested in virus-induced neurological complications – in particular, the influence of viral infections on the onset and progression of neurodegenerative diseases.
Miller Laboratory
Mucosal Vaccines and Therapeutics
Defining the functions of IgA during viral infection
Mucosal vaccine development
Passive mucosal immunization strategies
Pandemic Preparedness
Trained innate immunity
Novel antiviral strategies
Broadly-protective immunity against respiratory viruses
Virus-Host Interactions
Role of viral infections in ALS and other genetic diseases